Precision Health Analytics · Healthcare Performance Intelligence
Precision Health Analytics Across Every Signal You Already Collect
Vizier turns longitudinal biomarkers, genomic outputs, wearables, imaging, interventions and clinical history into evidence-grounded investigations—without replacing the systems that produced them.
See What Vizier Finds in Your DataBring the data you already collect. Keep the systems that produce it.
The buyer problem
More data has made interpretation harder for precision-health leaders, clinicians and data teams.
The data exists, but interpretation remains fragmented by vendor, modality and visit. The difficult question is no longer whether a marker is high today; it is what changed, what persisted, what else moved, and how strong the evidence is.
The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.
Where interpretation breaks
- Static reports isolate one modality
- Different clocks and identifiers break longitudinal review
- Normal-range values can still show meaningful personal movement
- Correlation is easily overstated as intervention effect
Data landscape
The signals involved
The job is not to force unlike data into one score. It is to preserve provenance, time, context and uncertainty while making the relationships investigable.
Blood biomarkers
Repeated laboratory values with units, methods, reference ranges and collection context.
Genomics and omics
Interpreted variants, risk outputs, epigenetic, proteomic and metabolomic results—not raw sequencing processing.
Wearables and imaging
Time-series physiology and structured imaging outputs with provenance.
Clinical context
Conditions, medications, supplements, interventions, symptoms and relevant history.
The intelligence layer
What Vizier adds
Trajectory intelligence
Separate noise from persistent improvement, deterioration and regime change.
Cross-signal investigation
Test whether related signals move together, diverge or remain unsupported.
Evidence-aware answers
Show provenance, confidence and uncertainty instead of manufacturing certainty.
Cohort comparison
Compare patterns across programmes while preserving clinically relevant context.
Interpretation discipline
Evidence before certainty
Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.
Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.
The distinctions that matter
- Association is not causality; timing and confounding still matter.
- Genetic predisposition is not the same as expressed phenotype.
- Biomarker movement is not automatically a clinical outcome.
- A biological-age estimate is model output, not a lifespan prediction.
Clear product boundary
What Vizier does—and does not—replace
Keep the EHR, laboratory, genomics provider, imaging archive and wearable systems. Vizier is the downstream intelligence layer across their authorised outputs.
Vizier consumes authorised outputs from the systems you choose. Source access, format, identity matching, governance, hosting and clinical review responsibilities are confirmed during discovery.
Vizier is not
- A sequencing or FASTQ/BAM/VCF processing pipeline
- A laboratory, EHR, scheduling, billing or CRM system
- A diagnostic device or autonomous clinical decision-maker
- A claim that an intervention caused a later change
Workflow
From fragmented outputs to a reviewable investigation
01
Inventory authorised sources, identifiers, time semantics and decision questions.
02
Validate units, mappings, provenance, missingness and clinically relevant comparison periods.
03
Configure longitudinal and cross-signal investigations around the organisation's reviewed definitions.
04
Return findings with evidence, uncertainty and a traceable path back to source data.
Questions buyers ask
Frequently asked questions
What is precision health analytics?
Precision Health Analytics is the governed analysis of relevant health data for longitudinal and cross-signal questions. For Vizier, that means analysing authorised outputs while retaining provenance, time and uncertainty.
Does Vizier replace our existing clinical or diagnostic systems?
Keep the EHR, laboratory, genomics provider, imaging archive and wearable systems. Vizier is the downstream intelligence layer across their authorised outputs.
Can Vizier prove that an intervention caused a change?
Not from timing alone. Vizier can align observations to an intervention, show competing explanations and describe the strength of evidence. Causal claims require an appropriate design and expert review.
How does implementation start?
With one decision question and a source inventory. Vizier validates access, identifiers, units, time semantics, governance and the review workflow before a capability is represented as production-ready.
Precision Health Answers
Start with the buyer questions
See precision health analytics across the data you already collect.
Bring the data you already collect. See what Vizier finds across it.
Start with the data you already have. Connect your EHR when you’re ready.